LEIDEN, The Netherlands, Aug. 24,
2023 /PRNewswire/ -- Pharming Group N.V.
("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces
that Pharming's management will participate in the following
investor conferences in the U.S. in the month of September:
- 2023 Wells Fargo Healthcare Conference, Boston, September
6-8
Sijmen de Vries, Chief Executive Officer, and Michael Levitan, VP
Investor Relations and Corporate Communications, will participate
in a fireside chat question and answer session on Thursday, September 7 at 16:30 ET/22:30 CET.
A live webcast and replay of the fireside chat will be available in
the "Upcoming Events" and "News" sections of Pharming's
website.
- H.C. Wainwright 25th Annual Global Investment
Conference, New York, September 11-13
Sijmen de Vries, Chief Executive Officer, will present on
Wednesday, September 13 at
08:30 ET/14:30
CET. A live webcast and replay of the presentation will be
available in the "Upcoming Events" and "News" sections of
Pharming's website.
- 2023 Cantor Global Healthcare Conference, New York, September
26-28
Michael Levitan, VP Investor Relations and Corporate
Communications, will present on Thursday,
September 28 at 10:20
ET/16:20 CET.
For more information about these conferences, or to schedule a
one-to-one meeting with Pharming's management team, please contact
Pharming's Investor Relations team at investor@pharming.com or your
Wells Fargo, H.C. Wainwright or Cantor representative.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is
a global biopharmaceutical company dedicated to transforming the
lives of patients with rare, debilitating, and life-threatening
diseases. Pharming is commercializing and developing an innovative
portfolio of protein replacement therapies and precision medicines,
including small molecules, biologics, and gene therapies that are
in early to late-stage development. Pharming is headquartered in
Leiden, Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle
East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com and find us on
LinkedIn.
For further public information, contact:
Pharming Group, Leiden, The
Netherlands
Michael Levitan, VP Investor Relations & Corporate
Communications
T: +1 (908) 705 1696
Heather Robertson, Investor
Relations & Corporate Communications Manager
E: investor@pharming.com
FTI Consulting, London,
UK
Victoria Foster
Mitchell/Alex
Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon
Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pharming-group-to-participate-in-september-investor-conferences-301906969.html
SOURCE Pharming Group N.V.
